Mexicantown Wholesale of Detroit, Michigan is recalling all lots of PAN NUEZ because they contain undeclared pecan chips. People who have an allergy or severe sensitivity to pecans run the risk of serious or life-threatening allergic reaction if they consume these products. Mexicantown Wholesale of Detroit, Michigan is also recalling all lots of PAN NUEZ, MAGDALENA, PAN DE MAIZ, YOYO and TACOS DE PAN DANES manufactured between 6/27/2010 and 12/28/2010, because they contain undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume these products. The recalled PAN NUEZ, MAGDALENA, PAN DE MAIZ, YOYO and TACOS DE PAN DANES also contain undeclared wheat and FD&C Yellow#5, which can elicit moderate reactions in sensitive individuals.
Moog Recalls Curlin Ambulatory Infusion Pump Models 6000 CMS, 6000 CMS IOD, PainSmart, and PainSmart IOD
EAST AURORA, NY–(Marketwire – April 08, 2011) – Moog Inc. (NYSE: MOG.A) (NYSE: MOG.B) announced today that the Food and Drug Administration (FDA) has classified the voluntary correction of the Curlin 6000 CMS, Curlin 6000 CMS IOD, PainSmart, and PainSmart IOD as a Class I recall. The affected models were manufactured and updated from May 2007 to February 2011. The decision to conduct the device recall is due to a software anomaly which leads to software Error Code 45 (EC45), resulting in a shutdown of the pump. This failure may result in a delay or interruption of therapy, which could result in serious injury and/or death. To date there have been no adverse patient events reported to the Company.
FDA permits marketing of first test to help diagnose dengue fever
The U.S. Food and Drug Administration today allowed marketing of the first test to help diagnose people with signs and symptoms of dengue fever or dengue hemorrhagic fever, a leading cause of illness and death in the tropics and subtropics.
FDA clears single-use antibacterial surgical respirator
The U.S. Food and Drug Administration cleared the SpectraShield 9500 N95 surgical respirator, a device that kills 99.99 percent of three different kinds of bacteria when exposed to its outer surface.
Waco’s Bestyett Sandwiches issues a Voluntary Recall of Pimento Cheese Sandwiches and Chicken Salad Sandwiches due to Undeclared EGGS
Waco’s Bestyett Sandwiches of Waco, Texas, is voluntarily recalling its 3.5 ounce packages of Pimento Cheese Sandwiches and Chicken Salad Sandwiches because they contain undeclared eggs. Individuals that have an allergy to eggs run the risk of serious or life-threatening allergic reaction if they consume these products
bioMérieux, Inc. Issues Urgent Expanded Product Recall for VITEK® 2 Piperacillin/Tazobactam Test on Gram Negative Susceptibility Cards
As a follow up to the communication issued on September 16, 2010, bioMérieux, Inc. is voluntarily expanding its worldwide product recall of VITEK® 2 Gram Negative Susceptibility Cards containing the antibiotic Piperacillin/Tazobactam. These cards, manufactured after March 10, 2009, are used in clinical laboratories to perform antimicrobial susceptibility testing as part of the VITEK® 2 System.
FDA clears test for bacteria that can cause serious intestinal disease
The U.S. Food and Drug Administration today cleared a test called the Cepheid Xpert C. difficile/Epi assay that is designed to rapidly detect the toxin B gene associated with Clostridium difficile infection (CDI), a cause of diarrhea that can lead to colitis, other serious intestinal conditions and death in severe cases.
Tri-Union Seafoods Issues Precautionary, Voluntary Recall Of Limited 6.5-Ounce Chopped Clams
Tri-Union Seafoods LLC is issuing a precautionary, voluntary recall of a limited amount of Chicken of the Sea brand 6.5-ounce chopped clams. The product is mislabeled and may contain tiny shrimp, and the company is conducting this precautionary, voluntary recall to ensure public health as shellfish is considered an allergen.
FDA approves Horizant to treat restless legs syndrome
On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets (gabapentin enacarbil), a once-daily treatment for moderate-to-severe restless legs syndrome (RLS).
FDA approves new treatment for rare form of thyroid cancer
medullary, thyroid cancer